SOLO- SOLTI 1113
Clinical Trial Program
Sentinel lymph node total tumoral load as a predictor of non-sentinel node involvement in early breast cancer patients
Status
Finished
Tumour subtype:
HER2+, HR+, TNBC
Scenario
Adjuvant
SPONSOR
COLLABORATORS
PRINCIPAL INVESTIGATORS
Vicente Peg, MD, PhD (Hospital Universitari Vall d'Hebron, Barcelona)
Martín Espinosa, MD (Hospital Universitari Vall d'Hebron, Barcelona)
Isabel Rubio, MD (Hospital Universitari Vall d'Hebron, Barcelona)
